Dahlman Rose Increases Molycorp PT To $125, Reiterates Buy (MCP)
Dahlman Rose increased its Molycorp (NYSE: MCP) price target from $85 to $125 and reiterated Molycorp's Buy rating in a research report published today.
In the report, Dahlman Rose states, "We have gained further comfort into the sustainability of rare earth pricing over the medium- to long-term, as increasing rare earth prices in the Chinese market should support prices globally. Based upon our revised price deck, we are increasing our price target to $125 and reiterating our Buy rating."
Shares of Molycorp closed today at $71.52, down 2.43% from Friday's market close.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.